New insulin sensitivity adjusted β cell indices: Validation according to a genetic study

Nursing

Volumn 27, Issue 2, 1997, Pages

  Chiu, Ken C ^a   Martinez, Dorothy S ^a   Lee, Nancy P ^b   Saad, Mohammed F ^c  

^a Division of Endocrinology Diabetes and Hypertension   (United States)

^b Division of Clinical Epidemiology and Preventive Medicine   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hepatocyte nuclear factor 1 ; Insulin sensitivity; Single nucleotide polymorphism; Type II (non insulin dependent) diabetes; cell function

Indexed keywords

DNA BINDING PROTEIN; GLUCOSE; HEPATOCYTE NUCLEAR FACTOR 1; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HEPATOCYTE NUCLEAR FACTOR 1BETA; INSULIN; NUCLEAR PROTEIN; TCF1 PROTEIN, HUMAN; TCF2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ADULT; ARTICLE; BLOOD; CLINICAL TRIAL; DIET RESTRICTION; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HUMAN; INSULIN RESISTANCE; INTRAVENOUS DRUG ADMINISTRATION; MALE; METABOLISM; MULTIVARIATE ANALYSIS; PANCREAS ISLET; PHYSIOLOGY; REGRESSION ANALYSIS; TIME;

ADULT; BLOOD GLUCOSE; DNA-BINDING PROTEINS; FASTING; FEMALE; GENOTYPE; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HEPATOCYTE NUCLEAR FACTOR 1; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HEPATOCYTE NUCLEAR FACTOR 1-BETA; HUMANS; INFUSIONS, INTRAVENOUS; INSULIN; INSULIN RESISTANCE; ISLETS OF LANGERHANS; MALE; MULTIVARIATE ANALYSIS; NUCLEAR PROTEINS; POLYMORPHISM, GENETIC; REGRESSION ANALYSIS; TIME FACTORS; TRANSCRIPTION FACTORS;

EID: 2142835891     PISSN: 03604039     EISSN: 15388689     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991; 14:173-194.
2. Haffner SM, D’Agostino R, Saad MF, et al. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes. 1996; 45:742-748.
3. Martin BC, Warram JH, Krolewski AS, et al. Role of glucose and insulin resistance in development of type II diabetes mellitus: results of a 25-year follow-up study. Lancet. 1992; 340:925-929.
4. Gerich JE. Insulin resistance is not necessarily an essential component of type II diabetes. J Clin Endocrinol Metab. 2000; 85:2113-2115.
5. Kahn BB. Type II diabetes: when insulin secretion fails to compensate for insulin resistance. Cell. 1998; 92:593-596.
6. Porte DJ. Clinical importance of insulin secretion and its interaction with insulin resistance in the treatment of type II diabetes mellitus and its complications. Diabetes Metab Res Rev. 2001; 17:181-188.
7. Elbein SC, Wegner K, Kahn SE. Reduced beta-cell compensation to the insulin resistance associated with obesity in members of Caucasian familial type II diabetic kindreds. Diabetes Care. 2000; 23:221-227.
8. Gautier JF, Wilson C, Weyer C, et al. Low acute insulin secretory responses in adult offspring of people with early onset type II diabetes. Diabetes. 2001; 50:1828-1833.
9. Pimenta W, Korytkowski M, Mitrakou A, et al. Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative. JAMA. 1995; 273:1855-1861.
10. Ehrmann DA, Sturis J, Byrne MM, et al. Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. J Clin Invest. 1995; 96:520-527.
11. Haffner SM, Miettinen H, Gaskill SP, et al. Decreased insulin action and insulin secretion predict the development of impaired glucose tolerance. Diabetologia. 1996; 39:1201-1207.
12. Weyer C, Bogardus C, Mott DM, et al. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type II diabetes mellitus. J Clin Invest. 1999; 104:787-794.
13. Buchanan TA, Xiang AH, Kjos SL, et al. Antepartum predictors of the development of type II diabetes in Latino women 11-26 months after pregnancies complicated by gestational diabetes. Diabetes. 1999; 48:2430-2436.
14. Lillioja S, Mott DM, Spraul M, et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med. 1993; 329:1988-1992.
15. Groop LC, Widaen E, Ferrannini E. Insulin resistance and insulin deficiency in the pathogenesis of type II (non-insulin-dependent) diabetes mellitus: errors of metabolism or of methods? Diabetologia. 1993; 36:1326-1331.
16. DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care. 1992; 15:318-368.
17. Yamagata K, Oda N, Kaisaki PJ, et al. Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3). Nature. 1996; 384:455-458.
18. Vaxillaire M, Rouard M, Yamagata K, et al. Identification of nine novel mutations in the hepatocyte nuclear factor 1 alpha gene associated with maturity-onset diabetes of the young (MODY3). Hum Mol Genet. 1997; 6:583-586.
19. Chiu KC, Chuang LM, Chu A, et al. Transcription factor 1 and beta-cell function in glucose-tolerant subjects. Diabetes Medicine. 2003; 20:225-230.
20. Chiu KC, Chuang L-M, Chu A, et al. Wang M. Comparison of the impact of the I27L polymorphism of the hepatocyte nuclear factor-1alpha on estimated and measured beta cell indices. Eur J Endocrinol. 2003; 148:641-647.
21. Ferrannini E, Buzzigoli G, Bonadonna R, et al. Insulin resistance in essential hypertension. N Engl J Med. 1987; 317:350-357.
22. Rossetti L, Giaccari A, DeFronzo RA. Glucose toxicity. Diabetes Care. 1990; 13:610-630.
23. Chiu KC, Lee NP, Cohan P, et al. Beta cell function declines with age in glucose tolerant caucasians. Clin Endocrinol (Oxf). 2000; 53:569-575.
24. Kahn SE, Prigeon RL, McCulloch DK, et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes. 1993; 42:1663-1672.
25. Buchanan TA. Pancreatic B-cell defects in gestational diabetes: implications for the pathogenesis and prevention of type II diabetes. J Clin Endocrinol Metab. 2001; 86:989-993.
26. Lee YH, Sauer B, Gonzalez FJ. Laron dwarfism and non-insulin-dependent diabetes mellitus in the Hnf-1alpha knockout mouse. Mol Cell Biol. 1998; 18:3059-3068.
27. Pontoglio M, Barra J, Hadchouel M, et al. Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome. Cell. 1996; 84:575-585.
28. Ellard S. Hepatocyte nuclear factor 1 alpha (HNF-1 alpha) mutations in maturity-onset diabetes of the young. Hum Mutat. 2000; 16:377-385.
29. Mahtani MM, Widaen E, Lehto M, et al. Mapping of a gene for type II diabetes associated with an insulin secretion defect by a genome scan in Finnish families. Nat Genet. 1996; 14:90-94.
30. Bowden DW, Sale M, Howard TD, et al. Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy. Diabetes. 1997; 46:882-886.
31. Ehm MG, Karnoub MC, Sakul H, et al. Genomewide search for type II diabetes susceptibility genes in four American populations. Am J Hum Genet. 2000; 66:1871-1881.
32. Shaw JT, Lovelock PK, Kesting JB, et al. Novel susceptibility gene for late-onset NIDDM is localized to human chromosome 12q. Diabetes. 1998; 47:1793-1796.